A21.0
Ulceroglandular tularemia
Clinical Classification Guidelines
Medical Intelligence & Overview
Ulceroglandular tularemia is a bacterial infection caused by Francisella tularensis. It is a form of tularemia that primarily affects the skin and nearby lymph nodes. This condition is typically contracted through contact with infected animals or contaminated environments, leading to localized skin ulcers and swollen lymph nodes. Although uncommon, it can be serious if not identified and treated promptly.
Causes & Symptoms
Clinical Causes: Handling infected animals, especially rabbits, rodents, and hares Bites from ticks, deer flies, or other insects carrying the bacteria Inhalation of contaminated dust or aerosols, especially in occupational settings Contact with contaminated water or soil Ingestion of contaminated food or water
Key Symptoms: A painful skin ulcer at the site of infection Swollen and tender lymph nodes near the ulcer, often in the neck, armpit, or groin Fever and chills Headache and muscle aches Fatigue and malaise Occasional skin redness and swelling around the ulcer
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical assessment and laboratory tests. Blood tests may detect antibodies or bacteria presence, while a culture of the infected tissue or lymph nodes can confirm the diagnosis. Imaging studies are rarely necessary but may be used if complications develop. A thorough history of exposure to potential sources of infection can aid in suspicion of tularemia.
Treatment Protocols: The primary treatment for ulceroglandular tularemia is targeted antibiotic therapy. Common antibiotics include streptomycin, gentamicin, doxycycline, or ciprofloxacin. Duration of treatment generally ranges from 10 to 21 days, depending on the severity of the infection and patient response. Supportive care and wound management are also essential to promote healing and prevent secondary infections.
Clinical Advice & FAQs
Billing Guidance
Is A21.0 a billable ICD-10 code?
Yes, A21.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A21.0?
Clinical documentation must specify the nature of Ulceroglandular tularemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
